THC Farmaceuticals Inc
THC Farmaceuticals, Inc. owns and operates non-financial institution cash-dispensing automated teller machines at third-party owned retail and commercial locations. The company's machines are placed in hotels, stores, bowling alleys, and other high customer traffic areas for small and medium sized businesses. As of June 30, 2015, it had a total of eight machines for public use along the Wasatch F… Read more
THC Farmaceuticals Inc (CBDG) - Total Liabilities
Latest total liabilities as of June 2022: $594.97K USD
Based on the latest financial reports, THC Farmaceuticals Inc (CBDG) has total liabilities worth $594.97K USD as of June 2022.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
THC Farmaceuticals Inc - Total Liabilities Trend (2011–2023)
This chart illustrates how THC Farmaceuticals Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
THC Farmaceuticals Inc Competitors by Total Liabilities
The table below lists competitors of THC Farmaceuticals Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Pathkey.ai Ltd
AU:PKY
|
Australia | AU$781.65K |
|
National Health Scan
PINK:GEGR
|
USA | $630.85K |
|
Rafex Gold Corp.
PINK:RAFX
|
USA | $267.38K |
|
Bank Maybank Indonesia Tbk PT
JK:BNII
|
Indonesia | Rp160.63 Trillion |
|
Zhuding International Ltd
PINK:ZHUD
|
USA | $0.00 |
|
SHENGLI OIL & GAS
MU:GSG
|
Germany | €580.15 Million |
Liability Composition Analysis (2011–2023)
This chart breaks down THC Farmaceuticals Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.12 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.21 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.21 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how THC Farmaceuticals Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for THC Farmaceuticals Inc (2011–2023)
The table below shows the annual total liabilities of THC Farmaceuticals Inc from 2011 to 2023.
| Year | Total Liabilities | Change |
|---|---|---|
| 2023-09-30 | $142.09K | 0.00% |
| 2022-09-30 | $142.09K | -75.82% |
| 2021-09-30 | $587.66K | +6.58% |
| 2020-09-30 | $551.40K | -49.27% |
| 2019-09-30 | $1.09 Million | +13.35% |
| 2018-09-30 | $958.96K | -0.07% |
| 2017-09-30 | $959.67K | +0.70% |
| 2016-09-30 | $952.98K | +990829.60% |
| 2014-09-30 | $96.17 | +45.71% |
| 2013-09-30 | $66.00 | -99.85% |
| 2012-09-30 | $45.23K | +130.72% |
| 2011-09-30 | $19.60K | -- |